Trends in Women With an HIV Diagnosis at Delivery Hospitalization in the United States, 2006-2014
- PMID: 32649273
- PMCID: PMC7383760
- DOI: 10.1177/0033354920935074
Trends in Women With an HIV Diagnosis at Delivery Hospitalization in the United States, 2006-2014
Abstract
Objectives: The risk of mother-to-child HIV transmission can be reduced to ≤0.5% if the mother's HIV status is known before delivery. This study describes 2006-2014 trends in diagnosed HIV infection documented on delivery discharge records and associated sociodemographic characteristics among women who gave birth in US hospitals.
Methods: We analyzed data from the 2006-2014 National Inpatient Sample and identified delivery discharges and women with diagnosed HIV infection by using International Classification of Diseases, Ninth Revision, Clinical Modification codes. We used a generalized linear model with log link and binomial distribution to assess trends and the association of sociodemographic characteristics with an HIV diagnosis on delivery discharge records.
Results: During 2006-2014, an HIV diagnosis was documented on approximately 3900-4400 delivery discharge records annually. The probability of having an HIV diagnosis on delivery discharge records decreased 3% per year (adjusted relative risk [aRR] = 0.97; 95% CI, 0.94-0.99), with significant declines identified among white women aged 25-34 (aRR = 0.93; 95% CI, 0.88-0.97) or those using Medicaid (aRR = 0.93; 95% CI, 0.90-0.97); among black women aged 25-34 (aRR = 0.95; 95% CI, 0.92-0.99); and among privately insured women who were black (aRR = 0.96; 95% CI, 0.92-0.99), Hispanic (aRR = 0.92; 95% CI, 0.86-0.98), or aged 25-34 (aRR = 0.96; 95% CI, 0.92-0.99). The probability of having an HIV diagnosis on delivery discharge records was greater for women who were black (aRR = 8.45; 95% CI, 7.56-9.44) or Hispanic (aRR = 1.56; 95% CI, 1.33-1.83) than white; for women aged 25-34 (aRR = 2.33; 95% CI, 2.12-2.55) or aged ≥35 (aRR = 3.04; 95% CI, 2.79-3.31) than for women aged 13-24; and for Medicaid recipients (aRR = 2.70; 95% CI, 2.45-2.98) or the uninsured (aRR = 1.87; 95% CI, 1.60-2.19) than for privately insured patients.
Conclusion: During 2006-2014, the probability of having an HIV diagnosis declined among select sociodemographic groups of women delivering neonates. High-impact prevention efforts tailored to women remaining at higher risk for HIV infection can reduce the risk of mother-to-child HIV transmission.
Keywords: HIV; delivery; mother-to-child transmission; national estimates; perinatal.
Conflict of interest statement
Figures
Similar articles
-
Hospitalizations up to 8 years following delivery in assisted reproductive technology-treated and subfertile women.Fertil Steril. 2022 Mar;117(3):593-602. doi: 10.1016/j.fertnstert.2021.11.012. Epub 2022 Jan 17. Fertil Steril. 2022. PMID: 35058044 Free PMC article.
-
Increasing Syphilis Diagnoses Among Females Giving Birth in US Hospitals, 2010-2014.Sex Transm Dis. 2019 Mar;46(3):147-152. doi: 10.1097/OLQ.0000000000000945. Sex Transm Dis. 2019. PMID: 30461596 Free PMC article.
-
Adolescent and young pregnant women at increased risk of mother-to-child transmission of HIV and poorer maternal and infant health outcomes: A cohort study at public facilities in the Nelson Mandela Bay Metropolitan district, Eastern Cape, South Africa.S Afr Med J. 2014 Dec;104(12):874-80. doi: 10.7196/samj.8207. S Afr Med J. 2014. PMID: 26042271
-
HIV infection and zidovudine use in childbearing women.Pediatrics. 2004 Dec;114(6):e707-12. doi: 10.1542/peds.2004-0414. Epub 2004 Nov 15. Pediatrics. 2004. PMID: 15545619
-
Pediatric AIDS and perinatal HIV infection in Zaire: epidemiologic and pathologic findings.Prog AIDS Pathol. 1992;3(1):1-33. Prog AIDS Pathol. 1992. PMID: 1606299 Review.
Cited by
-
Achieving Elimination of Perinatal HIV in the United States.Pediatrics. 2023 May 1;151(5):e2022059604. doi: 10.1542/peds.2022-059604. Pediatrics. 2023. PMID: 37070379 Free PMC article.
-
Rheumatoid arthritis and cardiovascular complications during delivery: a United States inpatient analysis.Eur Heart J. 2024 May 7;45(17):1524-1536. doi: 10.1093/eurheartj/ehae108. Eur Heart J. 2024. PMID: 38427130 Free PMC article.
References
-
- Centers for Disease Control and Prevention Recommendations of the US Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1994;43(RR-11):1-20. - PubMed
-
- Wortley PM., Lindegren ML., Fleming PL. Successful implementation of perinatal HIV prevention guidelines. MMWR Morb Mortal Wkly Rep. 2001;50(RR06):17-28. - PubMed
-
- Centers for Disease Control and Prevention Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1985;34(48):731-732. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical